Catalog Advanced Search

Search by Categories
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 2020 ACCP Virtual Journal Club June | Evaluation of the Effect of 5 QT-Positive Drugs on the JT peak Interval-An Analysis of ECGs From the IQ-CSRC Study - LIVE

    Contains 5 Component(s), Includes Credits Includes a Live Web Event on 06/17/2020 at 2:00 PM (EDT)

    Presented by: Borje Darpo, MD, PhD

    Evaluation of the Effect of QT-Positive Drugs on the JTpeak Interval-An Analysis of ECGs From the IQ-CSRC Study- LIVE

    ACCP Virtual Journal Club Webinars

    Live Session: Wednesday, June 17, 2020 from 2:00-3:00 PM ET

    On Demand: June 17, 2020 to May 20, 2023

    See Handouts tab for Continuing Education information on IPCE credits.


    Borje Darpo, MD, PhD

    Chief Scientific Officer, Cardiac Safety, ERT

    Borje Darpo, MD, PhD is board certified in cardiology and previously Associate Professor of Cardiology at the Karolinska Institute, Sweden. He specialized in clinical electrophysiology and presented his thesis on the clinical development of an antiarrhythmic drug in 1995. In 1998 he joined Pharmacia and has held positions as Clinical Program Leader in Cardiovascular, Regional Head of EU for Clinical Pharmacology and Senior Director in Pfizer’s Clinical Technologies group in Sandwich, UK. Between April 2004 and March 2006, Dr Darpo held the position as Chief Medical Officer of Daiichi Medical Research in UK and USA.

    In 1997 Dr. Darpo participated as a member of the expert committee that drafted the CPMP’s “Points to Consider” on clinical QT assessment. Dr Darpo represented the European Pharmaceutical industry (EFPIA) as deputy topic leader of the ICH E14 Expert Working Group and Implementation Working Group between 2000 and 2008.
    As the co-chair of the Scientific Oversight committee of CSRC, Dr Darpo led and coordinated the successful IQ-CSRC study, which contributed to the revision of the ICH E14 clinical guidance on QT assessment. He currently serves as the Chief Scientific Officer, Cardiac Safety of ERT, and works with sponsor clients on strategies for ECG assessment in clinical development and design and analysis of ECG studies.

    Ammar Raza, MD (Moderator)

    Regional Medical Director

    Dr. Ammar Raza is a physician specialized in Clinical Diabetology and an alumnus of Indian Institute of Management Bangalore (IIMB), with over 2 decades in Healthcare in diverse settings – Pharma majors (AstraZeneca, Novartis, Novo Nordisk, Allergan and Dr. Reddy’s), Pharma R & D (Strides Arcolab and Dr. Reddy’s), and Clinical practice settings (both Hospital- and office-based clinical diabetology practice). Sr Medical leader in biopharma in medical affairs and clinical development for innovative small molecules, biologics, vaccines, biosimilars, medical devices and branded generics across multiple therapeutic areas. Dr. Raza Contributed to clinical development and launch of many NCEs/ NBEs/ Medical device/ branded generics and Biosimilars across emerging markets including Insulin analogues, a DPPIV inhibitor, a SGLT2 Inhibitor, a GLP 1 analogue, a novel Anti platelet agent, Extended release beta blocker, Antibiotics, Vaccines, a Combination inhaler for Asthma/COPD, Novel Anaemia drug for CKD patients, dermal fillers, in addition to a biosimilar MAb and small molecules and supportive therapies in Oncology. Awarded Fellowship of the American College of Clinical Pharmacology (ACCP) in 2018 and got elected to the executive committee of the South Asia Chapter of ACCP (SAC-ACCP). Currently, serves on the Education committee of the American College of Clinical Pharmacology (ACCP). Recipient of many industry and other awards including ‘Best Citizens of India 2016 award’, ‘Rajiv Gandhi Gold Medal Award 2018’, IARDO Awards for Contribution in Medical Science-2018, and Industry awards (MD’s Circle of Excellence, AstraZeneca Global, Regional and Country level awards). Serves on the Editorial Board of International Journal of Basic & Clinical Pharmacology, as Honorary Visiting Faculty, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad and is listed among Global Pharmaceutical Sciences Experts by www.omiconline.org. Listed on the Worldwide Who’s Who Registry of executives, professionals and entrepreneurs. Recently nominated for Professional Certification in Translational Medicine (PCTM) by the Academy of Translational Medicine Professionals of the European Society for Translational Medicine (EUSTM).

  • 2020 ACCP Journal of Clinical Pharmacology Journal CE | Monthly CE Offerings

    Contains 24 Component(s), Includes Credits

    The American College of Clinical Pharmacology® monthly journal article continuing education offerings from The Journal of Clinical Pharmacology.

    Registration and Pricing

    The American College of Clinical Pharmacology® (ACCP) offers a monthly article from the The Journal of Clinical Pharmacology (JCP) for continuing education credit. See the CE Info tab for more information on credits. The ACCP JCP Journal CE articles are priced and packaged for January through December of the same calendar year. Packages are available at no cost to ACCP Members and $75/calendar year to Non-members. Once registered, learners have access to all of the Journal CE articles for the calendar year as the articles are released.

    To register, log into your ACCP online profile and then register by clicking the green Register button at the top right. Follow the online prompts to complete the registration process and to receive your registration confirmation. If you do not have an ACCP profile, one must be created before you can register for the Journal CE articles. If you do not know if you have a profile, please contact KLevy@ACCP1.org for further information to avoid creating duplicate profiles. Please address all other questions to CE@ACCP1.org.

    Requirements for Credits

    All requirements for claiming CE credits are listed in the CE Info tab. Continuing education credits and certificates must be claimed within 30-days of completing the monthly article offering. Continuing Pharmacy Education (CPE) data is uploaded into the CPE Monitor at the end of each month. The pharmacist's NABP# and MMDD of birth must be updated into their ACCP Profile or emailed to CE@ACCP1.org in order to have CPE credits automatically uploaded to the CPE Monitor.

    CE Expiration 12/31/2023




     

  • 2020 ACCP Virtual Journal Club May | Concept of Pharmacologic Target-Mediated Drug Disposition in Large-Molecule and Small-Molecule Compounds - On Demand

    Contains 5 Component(s), Includes Credits

    Presented by: Guohua An, MD, PhD

    Concept of Pharmacologic Target-Mediated Drug Disposition in Large-Molecule and Small-Molecule Compounds- On Demand

    ACCP Virtual Journal Club Webinars

    Live Session: Wednesday, May 20, 2020 from 2:00-3:00 PM ET

    On Demand: May 20, 2020 to May 20, 2023

    See Handouts tab for Continuing Education information on IPCE credits.

    Why is this webinar important to you? 

    Target-mediated drug disposition (TMDD) is a term to describe a nonlinear pharmacokinetics (PK) phenomenon that is caused by high-affinity binding of a compound to its pharmacologic targets. As the interaction between drug and its pharmacologic target belongs to the process of pharmacodynamics (PD), TMDD can be viewed as a consequence of “PD affecting PK”. Both large-molecule and small-molecule compounds can undergo TMDD. Learners that complete this course will explain how TMDD happens; why large-molecule and small-molecule compounds exhibiting TMDD demonstrate substantially different nonlinear PK behaviors; what nonlinear PK profiles look like in large-molecule and small-molecule compounds exhibiting TMDD; and how to identify whether the nonlinear PK of a compound is because of TMDD.


    Guohua An, MD, PhD

    Assistant Professor

     Dr. An joined Ruijin Hospital for 2 years as a clinical pharmacist and research scientist after receiving her MD from Taishan Medical College and MS in Clinical Pharmacology from Fudan Univ. Then she pursued a further study and got her PhD degree in Pharmaceutical Sciences from SUNY at Buffalo. Her graduate research focused on the role of transporter on the pharmacokinetics (PK) and pharmacodynamics (PD) of anticancer agents. Her research was further expanded after she joined the R&D group of Abbott, where she gained extensive hands on experience in clinical drug development, PK/PD modeling and simulation. Prior to joining Univ of Iowa, Dr. An worked at Univ of Florida as an Assistant Professor for one and half years. Her research interests include mechanism-based PK/PD modeling, model-informed drug development, pediatric clinical pharmacology, quantitative systems pharmacology, as well as applying proteomics in allometric scaling and IVIVE.  Dr. An has been in the PK/PD field for 15 years and has published 66 peer-reviewed articles. Dr. An serves as an editorial board member for The Journal of Clinical Pharmacology (since 2014), Journal of Pharmaceutical Sciences (since 2016), and The AAPS Journal (since 2020). 

    Alexander J. Prokopienko, PharmD, PhD (Moderator)

    Clinical Pharmacologist

    Dr. Prokopienko graduated from Albany Coll of Pharmacy with his PharmD and subsequently from the Univ of Pittsburgh with his PhD in Clinical Pharmaceutical Sciences. During his PhD, Alex was selected as a recipient of the AFPE Pre-Doctoral fellowship, NIH TL1 Post-Doctoral fellowship and NIH Clinical Research Loan Repayment Program. After completing his PhD, he joined Vertex Pharmaceuticals as a Clinical Pharmacologist. 

  • 2020 ACCP Webinar April | Tips and Tricks for Effective Presentations-On Demand

    Contains 4 Component(s), Includes Credits

    Learners will gain insights into effective formatting, organization, and presentation of their scientific findings to engage their audience.

    ACCP 2020 Webinar - Tips and Tricks for Effective Presentations - On Demand

    Live webinar: April 21, 2020  

    On-demand webinar recording:  April 21, 2020 to April 21, 2023

    Why is this article important to your practice? 

    Scientific discourse is driven by the active dissemination of research and knowledge at all stages of a career. One of the most common ways to communicate scientific findings is to present them at meetings, among peers or to the wider community and to discuss the findings to advance both one’s personal understanding and that of the audience.  Preparing a clear message to convey the findings of research, placing them in context without overwhelming the audience and providing a confident conclusion that helps to drive scientific innovation are components of a good presentation. This webinar combines tips & tricks on how to create and format a presentation to provide a consistent message and flow, as well as build on existing skills to further engage and drive the audience to get the message across. A successful presentation is an essential driver for scientific success, networking and a career in all areas of clinical pharmacology.


    Target Audience: 

    Inter-professional team of Physicians, Pharmacists, PhDs, Nurse Practitioners, Physician Assistants and Students.

    Learning Objectives: 

    After completing this activity, the learner will be able to:

    1. State the importance of clear and legible slides as part of a good oral presentation;
    2. Structure slide presentations in a logical and clear manner, in order to tell the scientific “story”;
    3. Use titles, figures and tables appropriately in slide presentations;
    4. Engage and develop good presentation skills and behaviors.

    To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.



    Michael Fossler, PharmD, PhD

    Vice-President, Clinical Development and Quantitative Sciences

    Dr. Fossler is Vice-President, Clinical Development and Quantitative Sciences, at Trevena, Inc. He received the Pharm. D. (1992) and PhD (1995) degrees from the Univ of Maryland. From 1995 to 2000, Dr. Fossler was employed by the FDA as a clinical pharmacology reviewer in the Division of Metabolic and Endocrine Drug Products.  In 1998, he was promoted to Senior Reviewer, and joined the Pharmacometrics group at FDA, where he was responsible for reviewing and performing population PK/PD analyses. He left the Agency in 2000 and joined the Clinical Pharmacokinetics Group at DuPont Pharmaceuticals, where he had major responsibility for PK/PD analyses in the cardiovascular and anti-inflammatory areas. In November, 2001, he joined GlaxoSmithKline (GSK), where he continued to work in the cardiovascular area and eventually headed a group of nine pharmacometrics scientists. He left GSK in 2015 to assume his present role at Trevena, Inc, where he heads up clinical pharmacology, clinical operations, biostatistics, programming and data management. Dr. Fossler is a Fellow of the American Foundation for Pharmaceutical Education, a Fellow of the American College of Clinical Pharmacology, a past President of the College and is an Honorary Regent.  He holds adjunct faculty appointments at the Univ of Maryland School of Pharmacy, Mercer Univ and the Univ of North Texas, and is on the faculty of the Univ of California’s American Course on Drug Development & Regulatory Science.

    Lorraine Rusch, PhD

    Vice President, Scientific Strategy & Commercial Development

    Dr. Rusch is the Vice President, Scientific Strategy & Commercial Development at Celerion. Dr. Rusch is a metabolism chemist by training, holding a PhD in Bioanalytical Chemistry and Laboratory Medicine. She has led IND and NDA programs at biotechnology companies as well as launched clinical pharmacology offerings in areas as diverse as human abuse liability, QTc cardiovascular safety assessment and metabolic disease offerings at leading CROs. As an experienced drug development professional, Dr. Rusch has significant preclinical and translational medicine expertise designing, overseeing and executing NDA-enabling studies with a focus on challenging areas of translational development. She provides clinical pharmacology leadership of the medical and operations clinical team for early clinical pharmacology studies evaluating the safety profiles of renally-eliminated novel drug candidates in potentially vulnerable or impaired patient populations.

    Oliver Grundmann, PhD (Moderator)

    Clinical Associate Professor, Director, Univ of Florida Coll of Pharmacy, Medical Chemistry

    Dr. Grundmann is the Clinical Associate Professor and Director of Graduate Programs in Clinical Toxicology & Pharmaceutical Chemistry at the Coll of Pharmacy, Univ of Florida. His primary research focus is centered on natural products, specifically with CNS activity for depression, anxiety and other mood disorders. Clinical investigations into potential integrative and complementary use of natural products in a variety of best practice settings have provided him with a wide range of collaborative opportunities. Aside from his research interests, Dr. Grundmann is a staunch advocate for interdisciplinary and collaborative teaching in a connected global world allowing him to travel and frequently meet with colleagues and students from all areas of the world. In a sense, both a holistic research and teaching approach. He has been a member of ACCP, a Fellow and serves currently on the Board of Regents. As part of his ongoing research collaborations, he is familiar with the significant efforts involved in writing and publishing a scientific manuscript.

    Alexander J. Prokopienko, PharmD, PhD (Moderator)

    Clinical Pharmacologist

    Dr. Prokopienko graduated from Albany Coll of Pharmacy with his PharmD and subsequently from the Univ of Pittsburgh with his PhD in Clinical Pharmaceutical Sciences. During his PhD, Alex was selected as a recipient of the AFPE Pre-Doctoral fellowship, NIH TL1 Post-Doctoral fellowship and NIH Clinical Research Loan Repayment Program. After completing his PhD, he joined Vertex Pharmaceuticals as a Clinical Pharmacologist. 

  • 2020 ACCP Virtual Journal Club March | Real-World Data Approaches for Early Detection of Potential Safety and Effectiveness Signals for Generic Substitution:A Metoprolol Extended-Release Case Study - ON DEMAND

    Contains 5 Component(s), Includes Credits

    Presented by: Joshua D. Brown, PharmD, PhD

    Real-World Data Approaches for Early Detection of Potential Safety and Effectiveness Signals for Generic Substitution: A Metoprolol Extended-Release Case Study- ON DEMAND

    ACCP Virtual Journal Club Webinars

    Live Session: Wednesday, March 11, 2020 from 2:00-3:00 PM ET

    On Demand: March 11, 2020 to March 11, 2023

    See Handouts tab for Continuing Education information on IPCE credits.


    Joshua Brown, PharmD, PhD

    Assistant Professor

    Joshua Brown joined the Dept. of Pharmaceutical Outcomes and Policy as an assistant professor in 2016. He has experience in clinical pharmacy, health economics and outcomes research, and pharmacoepidemiology across academic, pharmaceutical industry, and managed care. His past and ongoing clinical interests have been in the cardiovascular and hematology/oncology therapeutic areas including comparative effectiveness and safety research with a focus on anti-coagulation and quality of care in thrombotic conditions such as atrial fibrillation, venous thromboembolism, and cancer. His current research program and collaborations focus on research methods for pharmacoepidemiologic and pharmacoeconomic generic and biosimilar evaluations, developing real-world evaluations of drug-drug interactions, and drug re-purposing studies (e.g. aging and Parkinson’s Disease). In 2017, Brown was named a Claude D. Pepper Junior Scholar to conduct translational research in geriatric pharmacoepidemiology and healthy aging. His academic work has been funded by the NIH, FDA, Bill & Melinda Gates Foundation, and the PhRMA Foundation in addition to contracts with pharmaceutical industry. Dr. Brown has published over 75 research articles and holds several editorial positions with high impact specialty journals in pharmacy and cardiovascular diseases and is actively involved in AMCP, ISPE, and ISPOR scientific societies. Dr. Brown was awarded as the AMCP Foundation’s “New Practitioner” for his early career contributions to managed care pharmacy and as a National Academy of Medicine Emerging Leader in 2019.

    Mariam Ahmed, PhD (Moderator)

    Clinical Pharmacology Reviewer

    Dr. Mariam Ahmed is an early career clinical pharmacologist. She is currently a clinical pharmacology reviewer at the US Food and Drug Administration. Dr. Ahmed graduated from the University of Minnesota. Her thesis focused on applications of quantitative clinical pharmacology to rare diseases. 

  • 2020 ACCP Webinar February | Communicating Your Science: From Blank Screen to Published Article for Students, Trainees, and Early-Stage Professionals (and a refresher for everybody else)-ON DEMAND

    Contains 4 Component(s), Includes Credits

    Attendees that complete this webinar will expand their skill set to publish scientific manuscripts and expand written communication abilities.

    ACCP 2020 Webinar - Communicating Your Science: From Blank Screen to Published Article for Students, Trainees, and Early-Stage Professionals (and a refresher for everybody else)-On-Demand

    On-demand webinar recording:  February 3, 2020 to February 3, 2023

    Why is this article important to your practice? 

    At the completion of this webinar participants will expand their skill set to publish scientific manuscripts and expand written communication abilities.

    Target Audience: 

    Researchers, Physicians, Pharmacists, and other professionals requiring training in the professional competencies of peer reviewing. 

    Learning Objectives: 

    After completing this activity, the learner will be able to:

    1. Articulate the process and key steps of outlining, drafting, editing and submitting a manuscript to communicate research to the scientific community or within their current;
    2. Demonstrate their newly gained knowledge of the process of writing, reviewing, editing and revising draft scientific manuscripts in order to improve the likelihood of acceptance and provide a high quality revised manuscript;
    3. Recognize different manuscript formats (brief reports, short communication, expert opinion, full-length article, and review article) and appropriate supporting documents/supplemental material that are necessary to effectively communicate their scientific research results; 
    4. Deepen their expertise and understanding of the differences between journals and to choose the appropriate journal in order for their research to achieve the best exposure/impact;
    5. Recognize potential of target journal being a predatory or opportunistic journal.

    To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.



  • 2020 ACCP Virtual Journal Club January |Characterization of Severe Adverse Drug Reactions at a Free-Standing Children's Hospital-ON DEMAND

    Contains 5 Component(s), Includes Credits

    Presented by: Jennifer Goldman, MD, MS & Sara Suppes, PharmD

    Characterization of Severe Adverse Drug Reactions at a Free-Standing Children's Hospital- ON-DEMAND

    ACCP Virtual Journal Club Webinars

    Live Session: Wednesday, January 22, 2020 from 2:00-3:00 PM ET

    On Demand: January 22, 2020 to January 23, 2023

    See Handouts tab for Continuing Education information on IPCE credits.


    Jennifer Goldman, MD, MS

    Associate Professor, Pediatrics, Children's Mercy Kansas City

    Dr. Goldman is a pediatric infectious diseases physician and clinical pharmacologist. She serves as the Medical Director of both the Antimicrobial Stewardship Program and the Drug Safety Service at Children's Mercy in Kansas City. Dr. Goldman's primary research is focused on pediatric adverse drug reactions. She is investigating potential biomarkers that may predict and hopefully prevent severe adverse drug reactions in the future. Her long term goal is to individualize therapeutic treatment in children so that unintended consequences of medications can be avoided. Her research has been funded by the National Inst of Health, Kansas City Area Life Sciences Inst, and the Marion Merrell Dow Clinical Scholars Award.


    Sarah Suppes, PharmD

    Clinical Pharmacy Specialist

    Dr. Suppes is a Clinical Pharmacy Specialist in the Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation at Children’s Mercy - Kansas City and holds an adjunct faculty appointment at the University of Missouri-Kansas City (UMKC) School of Pharmacy.  She leads the Drug Safety Service which is a hospital-wide pharmacovigilance program, specializing in the identification and documentation of adverse drug reactions throughout the hospital.  She is actively involved in several clinical and research initiatives related to pediatric adverse drug reactions including the de-labeling of penicillin allergies in children and optimizing antimicrobial prescribing.  

    Claude Abdallah, MD, MS (Moderator) (Moderator)

    Associate Professor, Children's National Health System

    Dr. Abdallah is a Pediatric Anesthesiologist, Associate Professor, at Children's National Health System. Dr. Abdallah joined ACCP in 2013 and was actively involved in the Honors & Award Committee from 2014 – 2016. She then joined the Education Committee in 2016. Dr. Abdallah received an MD from St Joseph's Univ Medical School in Beirut, Lebanon and then received her Master's in Pharmacology from Université de Montréal, Canada. She performed her residency in Anesthesiology at Yale-New Haven Hosp followed by a fellowship in pediatric anesthesia at the Hosp for Sick Children, Toronto, Canada. She has authored several publications in peer reviewed journals, abstracts and presented her research regionally, nationally and internationally at educational and organizational venues. She has been in practice for more than 15 years and has an interest in clinical research and pharmacology. 


  • 2020 ACCP Webinar February | Communicating Your Science: From Blank Screen to Published Article for Students, Trainees, and Early-Stage Professionals (and a refresher for everybody else)-LIVE

    Contains 4 Component(s), Includes Credits

    Attendees that complete this webinar will expand their skill set to publish scientific manuscripts and expand written communication abilities.

    ACCP 2020 Webinar - Communicating Your Science: From Blank Screen to Published Article for Students, Trainees, and Early-Stage Professionals (and a refresher for everybody else)

    Live webinar: February 3, 2020  

    On-demand webinar recording:  February 3, 2020 to February 3, 2023

    Why is this article important to your practice? 

    At the completion of this webinar participants will expand their skill set to publish scientific manuscripts and expand written communication abilities.

    Target Audience: 

    Researchers, Physicians, Pharmacists, and other professionals requiring training in the professional competencies of peer reviewing. 

    Learning Objectives: 

    After completing this activity, the learner will be able to:

    1. Articulate the process and key steps of outlining, drafting, editing and submitting a manuscript to communicate research to the scientific community or within their current;
    2. Demonstrate their newly gained knowledge of the process of writing, reviewing, editing and revising draft scientific manuscripts in order to improve the likelihood of acceptance and provide a high quality revised manuscript;
    3. Recognize different manuscript formats (brief reports, short communication, expert opinion, full-length article, and review article) and appropriate supporting documents/supplemental material that are necessary to effectively communicate their scientific research results; 
    4. Deepen their expertise and understanding of the differences between journals and to choose the appropriate journal in order for their research to achieve the best exposure/impact;
    5. Recognize potential of target journal being a predatory or opportunistic journal.

    To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.



    Joseph S. Bertino Jr., PharmD, FCP, FCCP

    Editor-in-Chief The Journal of Clinical Pharmacology

    Dr. Bertino is currently a Principal at Bertino Consulting, located in Schenectady, NY.  He is an Associate Professor of Pharmacology at the College of Physicians and Surgeons, Columbia University, New York, NY and an adjunct Associate Professor at the University at Buffalo School of Pharmacy.  He is also an Honorary Professor, Hanoi University of Pharmacy and a Distinguished Professor of the Hai Phong University of Medicine and Pharmacy. Dr. Bertino received his B.S.Pharmacy and Pharm.D. degrees from the University at Buffalo in Buffalo, NY, USA.  He has published over 100 original research papers, review articles and book chapters and a textbook of pharmacogenomics. His publications have included work in the area of antimicrobial pharmacokinetics, pharmacodynamics and toxicity, drug-drug interactions, general clinical pharmacology, vaccine pharmacology and the application of pharmacogenetics and pharmacogenomics to the drug development process.

    He serves on the Editorial Board of The European Journal of Clinical Pharmacology and Antimicrobial Agents and Chemotherapy.  Dr. Bertino has served on the Food and Drug Administration’s Antiinfective and Antiviral Advisory Committees.  He also serves as the Editor-in-Chief of the Journal of Clinical Pharmacology.

     

    David J. Greenblatt MD, FCP

    Professor, Tuffs Univ School of Medicine, Editor-in-Chief, Clinical Pharmacology in Drug Development

    Dr. Greenblatt has been on the Faculty of Tufts University School of Medicine and the Staff of Tufts Medical Center since 1979.  He holds the Louis Lasagna, M. D., Endowed Professorship at Tufts University School of Medicine, in the Department of Immunology (formerly the Department of Pharmacology and Experimental Therapeutics), and is a senior faculty member in the Graduate Program in Pharmacology & Experimental Therapeutics at the Sackler School of Graduate Biomedical Sciences at Tufts University. He also holds appointments as Professor of Psychiatry, Medicine, and Anesthesia, Tufts University School of Medicine.  He has previously served as Chair of the Department of Pharmacology and Experimental Therapeutics at Tufts University School of Medicine, Program Director and Associate Program Director of the institution’s Clinical/Translational Research Center (formerly the General Clinical Research Center), and Chair of the Institutional Review Board. He is Editor-in-Chief of Clinical Pharmacology in Drug Development, operated by the American College of Clinical Pharmacology.  He also is Co-Editor-in-Chief, with Dr. Richard I. Shader, of the Journal of Clinical Psychopharmacology,

     

    A native of Newton, Massachusetts, Dr. Greenblatt is a Magna Cum Laude graduate of Amherst College (1966), where he was senior class president and co-captain of the varsity football team. After college he attended Harvard Medical School, graduating in 1970.  Thereafter he trained in internal medicine at the Montefiore Hospital, New York City (1970-1971), and on the Harvard Medical Service at Boston City Hospital (1971-1972).  Following a Fellowship in Clinical Pharmacology at Massachusetts General Hospital under the mentorship of Dr. Jan Koch-Weser (1972-1974), he stayed on to head the Clinical Pharmacology Unit at Mass. General from 1975 to 1979, at which time he moved to Tufts.

    Stephan Schmidt, PhD

    Associate Professor

    Dr. Schmidt is an endowed, tenured Associate Professor at the Univ of Florida’s Ctr for Pharmacometrics & Systems Pharmacology in Lake Nona, Orlando. He currently serves as the Associate Director of the Ctr. His research focuses on the development and application of mechanism-based drug-disease models in the area of antimicrobial chemotherapy, pediatrics, diabetes, cardiovascular safety and post-menopausal osteoporosis. Dr. Schmidt published more than 60 peer-reviewed articles in highly-respected journals in the clinical pharmacology arena as well as four book chapters. He is the lead editor of a book entitled, Applied Pharmacometrics, published in 2014 as part of an AAPS series on advancing pharmaceutical sciences. Dr. Schmidt received the Paul Ehrlich Society for Chemotherapy Thesis Award in 2010, the Univ of Florida Clinical Translational Science Inst Junior Faculty Pilot Program Award in 2012, the Univ of Florida Excellence Award for Assistant Professors in 2013 and the Tanabe Young Investigator Award from the American Coll of Clinical Pharmacology® (ACCP) in 2016. He serves as the Chair of the Special Interest Group on PK/PD and Systems Pharmacology of the Intl Pharmaceutical Federation (FIP) and the is the immediate Past Chair of the Systems Pharmacology Community for the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Dr. Schmidt is a Section Editor for the European Journal of Pharmaceutical Sciences and Editorial Board Member for The Journal of Clinical Pharmacology and ASCPT’s Pharmacometrics and Systems Pharmacology journal.

    Matthew B. Dufek, PhD

    Associate Director

    Dr. Dufek completed his graduate training at the University of North Carolina at Chapel Hill and is currently a Director of Clinical Development at AbbVie Inc in Chicago, IL. For over 20 years, Dr. Dufek has worked at several small biotechnology as well as large pharmaceutical companies. Joining AbbVie in 2012, he currently holds a position as a Director of Clinical Development in the Department of Clinical Pharmacology & Pharmacometrics where he helps lead the clinical pharmacology & clinical development strategy/team for the development of new pharmaceutical therapies as well as supporting a diverse portfolio of marketed products. These projects have included supporting therapeutic areas of pulmonary medicine, immunology, men’s & women’s health, anti-infective (HIV, RSV and HCV), oncology, renal and pediatrics therapies. Dr. Dufek has an interest and has lectured at many conferences throughout the world as a leading expert in the development of novel approaches for pediatric drug development.

    Oliver Grundmann, PhD

    Clinical Associate Professor, Director, Univ of Florida Coll of Pharmacy, Medical Chemistry

    Dr. Grundmann is the Clinical Associate Professor and Director of Graduate Programs in Clinical Toxicology & Pharmaceutical Chemistry at the Coll of Pharmacy, Univ of Florida. His primary research focus is centered on natural products, specifically with CNS activity for depression, anxiety and other mood disorders. Clinical investigations into potential integrative and complementary use of natural products in a variety of best practice settings have provided him with a wide range of collaborative opportunities. Aside from his research interests, Dr. Grundmann is a staunch advocate for interdisciplinary and collaborative teaching in a connected global world allowing him to travel and frequently meet with colleagues and students from all areas of the world. In a sense, both a holistic research and teaching approach. He has been a member of ACCP, a Fellow and serves currently on the Board of Regents. As part of his ongoing research collaborations, he is familiar with the significant efforts involved in writing and publishing a scientific manuscript.

  • 2019 ACCP Journal of Clinical Pharmacology Journal CE | Monthly CE Offerings

    Contains 48 Component(s), Includes Credits

    The American College of Clinical Pharmacology® monthly journal article continuing education offerings from The Journal of Clinical Pharmacology.

    Registration and Pricing

    The American College of Clinical Pharmacology® (ACCP) offers a monthly article from the The Journal of Clinical Pharmacology (JCP) for continuing education credit. See the CE Info tab for more information on credits. The ACCP JCP Journal CE articles are priced and packaged for January through December of the same calendar year. Packages are available at no cost to ACCP Members and $75/calendar year to Non-members. Once registered, learners have access to all of the Journal CE articles for the calendar year as the articles are released.

    To register, log into your ACCP online profile and then register by clicking the green Register button at the top right. Follow the online prompts to complete the registration process and to receive your registration confirmation. If you do not have an ACCP profile, one must be created before you can register for the Journal CE articles. If you do not know if you have a profile, please contact KLevy@ACCP1.org for further information to avoid creating duplicate profiles. Please address all other questions to CE@ACCP1.org.

    Requirements for Credits

    All requirements for claiming CE credits are listed in the CE Info tab. Continuing education credits and certificates must be claimed within 30-days of completing the monthly article offering. Continuing Pharmacy Education (CPE) data is uploaded into the CPE Monitor at the end of each month. The pharmacist's NABP# and MMDD of birth must be updated into their ACCP Profile or emailed to CE@ACCP1.org in order to have CPE credits automatically uploaded to the CPE Monitor.

    CE Expiration 12/31/2021




     

  • 2019 ACCP Virtual Journal Club November |Adverse Drug Reactions in Pediatrics: From Identification to Solutions using a National Active Surveillance Network - ON DEMAND

    Contains 5 Component(s), Includes Credits

    Presented by: Bruce Carleton, BSc, PharmD, FCP, FISPE, Professor and Chair, University of British Columbia & Reno Tanoshima, MD, PhD, Research Associate Dept of Pediatrics, Univ of British Columbia, BC Children's Hospital Research Institute

    Adverse Drug Reactions in Pediatrics: From Identification to Solutions using a National Active Surveillance Network - ON DEMAND

    ACCP Virtual Journal Club Webinars

    On Demand: November 6, 2019 to November 7, 2022

    See Handouts tab for Continuing Education information on IPCE credits.